Literature DB >> 22687834

Hydrogen may inhibit collagen-induced platelet aggregation: an ex vivo and in vivo study.

Satoru Takeuchi1, Kojiro Wada, Kimihiro Nagatani, Hideo Osada, Naoki Otani, Hiroshi Nawashiro.   

Abstract

OBJECTIVE: Hydrogen selectively reduces hydroxyl radicals and peroxynitrite, and numerous experimental and clinical studies suggest that hydrogen can exert potent cellular protective effects against a wide variety of diseases. Furthermore, there is increasing evidence that antioxidants can modulate platelet activation. The aim of the present study was to investigate the relationship between hydrogen and collagen-induced platelet aggregation.
METHODS: For human ex vivo studies, we collected blood samples from six healthy humans and added normal saline or hydrogen-rich saline to blood and platelet-rich plasma. We found that collagen (1 µg/mL)-induced platelet aggregation was significantly inhibited by hydrogen-rich saline compared with a normal saline group (p=0.044). For rat in vivo studies, animals (n=17) were exposed to either nitrogen-based mixed gas with hydrogen (H2 gas group; n=9) or without hydrogen (non-H2 gas group; n=8). Additionally, another animals (n=13) administered either normal (NS group; n=7) or hydrogen-rich saline (HS group; n=6) (5 ml/kg) via intravenous infusion. Blood samples were drawn from the vena cava before treatment and from the right ventricle after treatment. Collagen (12 µg/mL)-induced platelet aggregation was then measured.
RESULTS: Collagen-induced platelet aggregation was significantly decreased in H2 gas and HS group rats (p=0.042, 0.018, respectively), while there was no difference in non-H2 gas and NS group rats before and after treatment.
CONCLUSION: In summary, these data suggest that hydrogen may inhibit collagen-induced platelet aggregation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22687834     DOI: 10.2169/internalmedicine.51.7161

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Safety of intravenous administration of hydrogen-enriched fluid in patients with acute cerebral ischemia: initial clinical studies.

Authors:  Kimihiro Nagatani; Hiroshi Nawashiro; Satoru Takeuchi; Satoshi Tomura; Naoki Otani; Hideo Osada; Kojiro Wada; Hiroshi Katoh; Nobusuke Tsuzuki; Kentaro Mori
Journal:  Med Gas Res       Date:  2013-06-25

2.  Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles.

Authors:  Masatoshi Ichihara; Sayaka Sobue; Mikako Ito; Masafumi Ito; Masaaki Hirayama; Kinji Ohno
Journal:  Med Gas Res       Date:  2015-10-19

Review 3.  Molecular hydrogen: a preventive and therapeutic medical gas for various diseases.

Authors:  Li Ge; Ming Yang; Na-Na Yang; Xin-Xin Yin; Wen-Gang Song
Journal:  Oncotarget       Date:  2017-09-21

Review 4.  Medical Application of Hydrogen in Hematological Diseases.

Authors:  Liren Qian; Zhengcheng Wu; Jian Cen; Sergiu Pasca; Ciprian Tomuleasa
Journal:  Oxid Med Cell Longev       Date:  2019-11-28       Impact factor: 6.543

5.  Adverse effect of inhalational anesthetics on the developing brain.

Authors:  Mike Wang; John H Zhang; Richard L Applegate
Journal:  Med Gas Res       Date:  2014-02-14

6.  Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.

Authors:  Satoru Takeuchi; Kentaro Mori; Hirohiko Arimoto; Kazuya Fujii; Kimihiro Nagatani; Satoshi Tomura; Naoki Otani; Hideo Osada; Kojiro Wada
Journal:  BMC Neurol       Date:  2014-09-09       Impact factor: 2.474

7.  The Comparative Efficiency of Intraperitoneal and Intravitreous Injection of Hydrogen Rich Saline against N-Methyl-N-Nitrosourea Induced Retinal Degeneration: A Topographic Study.

Authors:  Ye Tao; Tao Chen; Wei Fang; Zhongjun Yan; Qinghua Yang; Yifei Huang; Linjun Yu; Lingling Fan
Journal:  Front Pharmacol       Date:  2017-08-29       Impact factor: 5.810

8.  Hydrogen therapy can be used to control tumor progression and alleviate the adverse events of medications in patients with advanced non-small cell lung cancer.

Authors:  Ji-Bing Chen; Xiao-Feng Kong; Feng Mu; Tian-Yu Lu; You-Yong Lu; Ke-Cheng Xu
Journal:  Med Gas Res       Date:  2020 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.